Has Opdualag been launched in China
The compound preparation Opdualag, consisting of nivolumab and ranibizumab, has not yet been launched in China. Patients need to obtain it through overseas channels and pay attention to the authenticity and expiration date of the drug.
1. Market status of drugs
(1) Opdulag: The dual immunization combination preparation has not been approved by the China National Medical Products Administration, and there is no legal supply channel for domestic medical institutions.
(2) Single drug situation: nivolumab has been launched in China, but rivarimumab as a novel LAG-3 inhibitor has not yet been separately approved.
2 Ways to Obtain and Risk Warning
(1) Overseas drug purchase: It can be purchased through approved medical institutions in the United States and other regions, and complete prescriptions and customs clearance documents must be provided.
(2) Risk Warning: Cross border drug purchases carry risks such as inadequate transportation and storage conditions, counterfeit and shoddy products, etc. It is recommended to verify drug qualifications through formal channels.
3. Medical insurance and alternative solutions
(1) Medical insurance coverage: Due to not being marketed domestically, this drug is not covered by national medical insurance reimbursement.
(2) Alternative treatment: You can consult a doctor to use marketed PD-1 monoclonal antibodies (such as nivolumab) for monotherapy.
- Previous:Dosage of Avirumab (Bavencio)
- Next:How to eat Opdualag
Disclaimer：《Has Opdualag been launched in China》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！